MoneyWorks4Me

The sales for the September 2021 quarter moved up 34.00% to Rs. 1223.08 millions as compared to Rs. 912.78 millions during the corresponding quarter last year.The Company has registered profit of Rs. 174.71  millions for the quarter ended September 2021, a growth of 14.77%  over Rs. 152.23 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 275.34 millions compared to 229.56 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1223.08 912.78 34.00 1223.08 912.78 34.00 1223.08 912.78 34.00
Other Income 1.63 10.91 -85.06 1.63 10.91 -85.06 1.63 10.91 -85.06
PBIDT 275.34 229.56 19.94 275.34 229.56 19.94 275.34 229.56 19.94
Interest 26.92 14.03 91.87 26.92 14.03 91.87 26.92 14.03 91.87
PBDT 248.42 215.53 15.26 248.42 215.53 15.26 248.42 215.53 15.26
Depreciation 23.18 11.31 104.95 23.18 11.31 104.95 23.18 11.31 104.95
PBT 225.24 204.22 10.29 225.24 204.22 10.29 225.24 204.22 10.29
TAX 50.53 51.99 -2.81 50.53 51.99 -2.81 50.53 51.99 -2.81
Deferred Tax 7.06 1.55 355.48 7.06 1.55 355.48 7.06 1.55 355.48
PAT 174.71 152.23 14.77 174.71 152.23 14.77 174.71 152.23 14.77
Equity 364.37 105.00 247.02 364.37 105.00 247.02 364.37 105.00 247.02
PBIDTM(%) 22.51 25.15 -10.49 22.51 25.15 -10.49 22.51 25.15 -10.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..